Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Преимущества барьерных методов терапии аллергического ринита
Преимущества барьерных методов терапии аллергического ринита
В.К.Прозорова, А.Г.Абросимов, В.В.Архипов. Преимущества барьерных методов терапии аллергического ринита. Справочник поликлинического врача. 2013; 5: 14–17.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Richardson G, Eick S, Jones R. How is the indoor environment related to asthma? Literature Review. J Adv Nurs 2005; 52 (3): 328–39.
2. Sheikh A, Hurwitz B, Shehata Y. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev 2007 (1): CD001563.
3. Gotzsche PC, Johansen HK. House dust mite control measures for asthma: systematic review. Allergy 2008; 63 (6): 646–59.
4. Morgan WJ, Crain EF, Gruchalla RS et al. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med 2004; 351 (11): 1068–80.
5. Eggleston PA, Butz A, Rand C et al. Home environmental intervention in inner-city asthma: a randomized controlled clinical trial. Ann Allergy Asthma Immunol 2005; 95 (6): 518–24.
6. Kattan M, Stearns SC, Crain EF et al. Costeffectiveness of a home-based environmental intervention for inner-city children with asthma. J Allergy Clin Immunol 2005; 116 (5): 1058–63.
7. Bjornsdottir US, Jakobinudottir S, Runarsdottir V, Juliusson S. The effect of reducing levels of cat allergen (Fel d 1) on clinical symptoms in patients with cat allergy. Ann Allergy Asthma Immunol 2003; 91 (2): 189–94.
8. Kilburn S, Lasserson TJ, McKean M. Pet allergen control measures for allergic asthma in children and adults. Cochrane Database Syst Rev 2003 (1): CD002989.
9. Bagnasco M, Morbelli S, Altrinetti V et al. Allergen biodistribution in humans. Chem Immunol Allergy 2003; 82: 33–43.
10. Bagnasco M, Mariani G, Passalacqua G et al. Absorption and distribution kinetics of the major Parietariajudaica allergen (Par j 1) administered by noninjectable routes in healthy human beings. J Allergy Clin Immunol 1997; 100 (1): 122–9.
11. Hens G, Bobic S, Reekmans K et al. Rapid systemic uptake of allergens through the respiratory mucosa. J Allergy Clin Immunol 2007; 120 (2): 472–4.
12. Bernadette Diethart and Professor Jean Emberlinof University of Worcester, UK; Richard Lewis, Worcestershire Royal Hospital, UK Presented as a Poster at EAACI XXVII Congress, Barcelona, Spain 7–11 June 2008.
13. Emberlin JC, Lewis RA. A double blind, placebo controlled cross-over trial of inert cellulose powder, by nasal provocation with grass pollen to assess efficacy of the product in controlling the symptoms of hay fever. Poster presented at EAACI, Vienna June 2006.
14. Emberlin J, Lewis R. Presented at EAACI, Vienna, Austria, June 2006.
15. Emberlin J, Lewis R. Curr Med Res Opin 2007: 23 (10): 22423–31.
16. Aivazis V, Bourli E, Maratou E et al. Study of Mucociliary Clearance and Peak Nasal Inspiratory. Flow Rate in Children Before and After Therapy with Natural Cellulose Powder. University of Thessaloniki, Greece. Presented at World Allergy Congress in Munich, Germany June 2005.
17. Захаржевская Т.В., Сидоренко И.В., Трескунов В.К. и др. Доклад на XVI Конгрессе «Человек и лекарство», Москва, 6–10 апреля 2009.
18. Geppe NA, Snegotskaya MN, Kolosova NG, Konopelko OU. Conductedatthe Clinicof Child Diseasesat TheI. M. Sechenov Moscow Medical Academy. An open comparative randomized study in order to evaluate the efficacy and safety of intranasal inert cellulose powder in preventing seasonal allergic rhinitis (SAR) in children. The study was conducted between April and June 2009 and presented as a Poster in EACCI. London, 2010.
19. Josling P, Steadman S. Use of cellulose powder for the treatment of seasonal allergic rhinitis. Adv Ther 2003; 20 (4): 213–9.
20. Emberlin JC, Lewis RA. A double blind placebo controlled trial of inert cellulose powder for the relief of symptoms of Hay fever in adults. Curr Med Res Opin 2006; 22 (2): 275–85.
21. Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic. Microbes Infect 1999; 1 (2): 125–9.
22. Josling P. Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey. Adv Ther 2001; 18 (4): 189–93.
23. Hiltunen R, Josling P, James M. Preventing airborne infection with an intranasal cellulose powder formulation (Nasaleze Travel). Adv Ther 2007; 24: 1144–50.
2. Sheikh A, Hurwitz B, Shehata Y. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev 2007 (1): CD001563.
3. Gotzsche PC, Johansen HK. House dust mite control measures for asthma: systematic review. Allergy 2008; 63 (6): 646–59.
4. Morgan WJ, Crain EF, Gruchalla RS et al. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med 2004; 351 (11): 1068–80.
5. Eggleston PA, Butz A, Rand C et al. Home environmental intervention in inner-city asthma: a randomized controlled clinical trial. Ann Allergy Asthma Immunol 2005; 95 (6): 518–24.
6. Kattan M, Stearns SC, Crain EF et al. Costeffectiveness of a home-based environmental intervention for inner-city children with asthma. J Allergy Clin Immunol 2005; 116 (5): 1058–63.
7. Bjornsdottir US, Jakobinudottir S, Runarsdottir V, Juliusson S. The effect of reducing levels of cat allergen (Fel d 1) on clinical symptoms in patients with cat allergy. Ann Allergy Asthma Immunol 2003; 91 (2): 189–94.
8. Kilburn S, Lasserson TJ, McKean M. Pet allergen control measures for allergic asthma in children and adults. Cochrane Database Syst Rev 2003 (1): CD002989.
9. Bagnasco M, Morbelli S, Altrinetti V et al. Allergen biodistribution in humans. Chem Immunol Allergy 2003; 82: 33–43.
10. Bagnasco M, Mariani G, Passalacqua G et al. Absorption and distribution kinetics of the major Parietariajudaica allergen (Par j 1) administered by noninjectable routes in healthy human beings. J Allergy Clin Immunol 1997; 100 (1): 122–9.
11. Hens G, Bobic S, Reekmans K et al. Rapid systemic uptake of allergens through the respiratory mucosa. J Allergy Clin Immunol 2007; 120 (2): 472–4.
12. Bernadette Diethart and Professor Jean Emberlinof University of Worcester, UK; Richard Lewis, Worcestershire Royal Hospital, UK Presented as a Poster at EAACI XXVII Congress, Barcelona, Spain 7–11 June 2008.
13. Emberlin JC, Lewis RA. A double blind, placebo controlled cross-over trial of inert cellulose powder, by nasal provocation with grass pollen to assess efficacy of the product in controlling the symptoms of hay fever. Poster presented at EAACI, Vienna June 2006.
14. Emberlin J, Lewis R. Presented at EAACI, Vienna, Austria, June 2006.
15. Emberlin J, Lewis R. Curr Med Res Opin 2007: 23 (10): 22423–31.
16. Aivazis V, Bourli E, Maratou E et al. Study of Mucociliary Clearance and Peak Nasal Inspiratory. Flow Rate in Children Before and After Therapy with Natural Cellulose Powder. University of Thessaloniki, Greece. Presented at World Allergy Congress in Munich, Germany June 2005.
17. Захаржевская Т.В., Сидоренко И.В., Трескунов В.К. и др. Доклад на XVI Конгрессе «Человек и лекарство», Москва, 6–10 апреля 2009.
18. Geppe NA, Snegotskaya MN, Kolosova NG, Konopelko OU. Conductedatthe Clinicof Child Diseasesat TheI. M. Sechenov Moscow Medical Academy. An open comparative randomized study in order to evaluate the efficacy and safety of intranasal inert cellulose powder in preventing seasonal allergic rhinitis (SAR) in children. The study was conducted between April and June 2009 and presented as a Poster in EACCI. London, 2010.
19. Josling P, Steadman S. Use of cellulose powder for the treatment of seasonal allergic rhinitis. Adv Ther 2003; 20 (4): 213–9.
20. Emberlin JC, Lewis RA. A double blind placebo controlled trial of inert cellulose powder for the relief of symptoms of Hay fever in adults. Curr Med Res Opin 2006; 22 (2): 275–85.
21. Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic. Microbes Infect 1999; 1 (2): 125–9.
22. Josling P. Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey. Adv Ther 2001; 18 (4): 189–93.
23. Hiltunen R, Josling P, James M. Preventing airborne infection with an intranasal cellulose powder formulation (Nasaleze Travel). Adv Ther 2007; 24: 1144–50.
Авторы
В.К.Прозорова, А.Г.Абросимов, В.В.Архипов
Кафедра клинической фармакологии ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава РФ
Кафедра клинической фармакологии ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава РФ
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.